Key result
Mexiletine outperforms quinidine in treating chronic ventricular ectopia despite limiting side effects.
Why the study?
Does mexiletine improve efficacy compared to quinidine in patients with chronic ventricular ectopia?
Population
Patients with chronic ventricular ectopia of various causes
Comparison
Mexiletine vs Quinidine
Design
RCT, parallel, randomized, double-blind
Authors
Loading...
Mexiletine may be prioritized over quinidine for chronic ventricular ectopia; RCT confirms superior efficacy while underscoring tolerability limits.
RCT
Double-blind
Parallel
Does mexiletine improve efficacy compared to quinidine in patients with chronic ventricular ectopia?
p-value: p=<0.05
Mexiletine is more effective than quinidine for treating chronic ventricular ectopia, though distinct side effects may limit its use in some patients.
Assey et al. (1985) conducted an RCT in Chronic ventricular ectopia. Mexiletine vs. Quinidine was evaluated on Efficacy in treating ventricular ectopia (p=<0.05). Mexiletine was statistically more effective than quinidine in treating chronic ventricular ectopia (P<0.05), although side effects limited its usefulness in some patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: